-Search query
-Search result
Showing 1 - 50 of 1,143 items for (author: thomas & ak)

EMDB-71654: 
EV-D68 in complex with G12 VHH
Method: single particle / : Klose T, Kuhn RJ

PDB-9pi7: 
EV-D68 in complex with G12 VHH
Method: single particle / : Klose T, Kuhn RJ, Center for Structural Biology of Infectious Diseases (CSBID)

EMDB-41497: 
Structure of the H-lobe of human MED12
Method: single particle / : Chen SF, Chao TC, Kim HJ, Tang HC, Khadka S, Li T, Murakami K, Boyer TG, Tsai KL

EMDB-41500: 
Structure of the kinase and central lobes of human CDK8 kinase module
Method: single particle / : Chen SF, Chao TC, Kim HJ, Tang HC, Khadka S, Li T, Murakami K, Boyer TG, Tsai KL

EMDB-71655: 
EV-D68 in complex with G12 Fc
Method: single particle / : Klose T, Kuhn RJ

PDB-9pi8: 
EV-D68 in complex with G12 Fc
Method: single particle / : Klose T, Kuhn RJ, Center for Structural Biology of Infectious Diseases (CSBID)

EMDB-65360: 
Structure of human proteasome ATPase-CP intermediate assembles with 15min rapaprotin addition
Method: single particle / : Wang WL, Yin DY, Mao YD

EMDB-65361: 
Structure of human proteasome ATPase-CP intermediate assembles with 90min rapaprotin addition
Method: single particle / : Wang WL, Yin DY, Mao YD

EMDB-65362: 
Structure of human proteasome ATPase-CP intermediate assembles with 90min rapaprotin addition
Method: single particle / : Wang WL, Yin DY, Mao YD

PDB-9vue: 
Structure of human proteasome ATPase-CP intermediate assembles with 15min rapaprotin addition
Method: single particle / : Wang WL, Yin DY, Mao YD

PDB-9vuf: 
Structure of human proteasome ATPase-CP intermediate assembles with 90min rapaprotin addition
Method: single particle / : Wang WL, Yin DY, Mao YD

PDB-9vug: 
Structure of human proteasome ATPase-CP intermediate assembles with 90min rapaprotin addition
Method: single particle / : Wang WL, Yin DY, Mao YD

EMDB-76891: 
70S ribosome containing RpmE2 from Neisseria gonorrhoeae
Method: single particle / : Malezyna K, Forehand AL, Criss AK, Jomaa A

EMDB-76892: 
70S ribosome containing RpmE from Neisseria gonorrhoeae
Method: single particle / : Malezyna K, Forehand AL, Criss AK, Jomaa A

EMDB-56664: 
Cryo-ET of IAV (WSN-M1-Udorn) supernatant
Method: electron tomography / : Peterl S, Chlanda P

EMDB-56667: 
Cryo-ET of IAV (WSN-M1-Udorn) pellet
Method: electron tomography / : Peterl S, Chlanda P

EMDB-56668: 
Cryo-ET of IAV (WSN-M1-Udorn) unfractionated
Method: electron tomography / : Peterl S, Chlanda P

EMDB-68747: 
Structure of CXCR4 in complex with a de-novo designed mini-protein antagonist
Method: single particle / : Banerjee R, Ganguly M, Banerjee N, Tiwari D, Muratspahic E, Baker D, Shukla AK

PDB-22xc: 
Structure of CXCR4 in complex with a de-novo designed mini-protein antagonist
Method: single particle / : Banerjee R, Ganguly M, Banerjee N, Tiwari D, Muratspahic E, Baker D, Shukla AK

EMDB-70909: 
Heteromeric GluA1/A2 in the inactive state, consensus refinement of LBD-TMD
Method: single particle / : Yen LY, Newton TP, Gangwar SP, Sobolevsky AI

EMDB-70910: 
Heteromeric GluA1/A2 in the inactive state, transmembrane domain (TMD)
Method: single particle / : Yen LY, Newton TP, Gangwar SP, Sobolevsky AI

EMDB-70911: 
Heteromeric GluA1/A2 in the inactive state, ligand binding domain (LBD)
Method: single particle / : Yen LY, Newton TP, Gangwar SP, Sobolevsky AI

EMDB-70912: 
Heteromeric GluA1/A2 in the inactive state, composite map of LBD-TMD
Method: single particle / : Yen LY, Sobolevsky AI, Newton TP, Gangwar SP

EMDB-70913: 
Heteromeric GluA1/A2 in the activated state, consensus refinement of ATD-LBD-TMD
Method: single particle / : Yen LY, Newton TP, Gangwar SP, Sobolevsky AI

EMDB-70914: 
Heteromeric GluA1/A2 in the activated state, ligand binding domain (LBD)
Method: single particle / : Yen LY, Newton TP, Gangwar SP, Sobolevsky AI

EMDB-70915: 
Heteromeric GluA1/A2 in the activated state, transmembrane domain (TMD)
Method: single particle / : Yen LY, Newton TP, Gangwar SP, Sobolevsky AI

EMDB-70916: 
Heteromeric GluA1/A2-CNIH1 in the activated state, consensus refinement of LBD-TMD
Method: single particle / : Yen LY, Newton TP, Gangwar SP, Sobolevsky AI

EMDB-70917: 
Heteromeric GluA1/A2-CNIH1 in the activated state, ligand binding domain (LBD)
Method: single particle / : Yen LY, Newton TP, Gangwar SP, Sobolevsky AI

EMDB-70918: 
Heteromeric GluA1/A2-CNIH1 in the activated state, transmembrane domain (TMD)
Method: single particle / : Yen LY, Newton TP, Gangwar SP, Sobolevsky AI

EMDB-70919: 
Composite map of GluA1/A2 in the activated state, in complex with positive allosteric modulator (R,R)-2b and agonist glutamate (ATD-LBD-TMD)
Method: single particle / : Yen LY, Sobolevsky AI, Newton TP, Gangwar SP

EMDB-70920: 
Heteromeric GluA1/A2-CNIH1 in the activated state, composite map of LBD-TMD
Method: single particle / : Yen LY, Newton TP, Gangwar SP, Sobolevsky AI

EMDB-70921: 
Heteromeric GluA1/A2 in the desensitized state, consensus refinement of ATD-LBD-TMD
Method: single particle / : Yen LY, Newton TP, Gangwar SP, Sobolevsky AI

EMDB-70922: 
Heteromeric GluA1/A2 in the desensitized state, amino-terminal domain (ATD)
Method: single particle / : Yen LY, Newton TP, Gangwar SP, Sobolevsky AI

EMDB-70923: 
Heteromeric GluA1/A2 in the desensitized state, ligand binding domain (LBD)
Method: single particle / : Yen LY, Newton TP, Gangwar SP, Sobolevsky AI

EMDB-70924: 
Heteromeric GluA1/A2 in the desensitized state, transmembrane domain (TMD)
Method: single particle / : Yen LY, Newton TP, Gangwar SP, Sobolevsky AI

EMDB-70925: 
Heteromeric GluA1/A2 in the desensitized state, composite map of ATD-LBD-TMD
Method: single particle / : Yen LY, Newton TP, Gangwar SP, Sobolevsky AI

EMDB-75274: 
Heteromeric GluA1/A2 in the activated state, amino-terminal domain (ATD)
Method: single particle / : Yen LY, Newton TP, Gangwar SP, Sobolevsky AI

PDB-9ovt: 
Heteromeric GluA1/A2 in the inactive state, composite map of LBD-TMD
Method: single particle / : Yen LY, Sobolevsky AI, Newton TP, Gangwar SP

PDB-9ovu: 
Composite map of GluA1/A2 in the activated state, in complex with positive allosteric modulator (R,R)-2b and agonist glutamate (ATD-LBD-TMD)
Method: single particle / : Yen LY, Sobolevsky AI, Newton TP, Gangwar SP

PDB-9ovv: 
Heteromeric GluA1/A2-CNIH1 in the activated state, composite map of LBD-TMD
Method: single particle / : Yen LY, Newton TP, Gangwar SP, Sobolevsky AI

PDB-9ovw: 
Heteromeric GluA1/A2 in the desensitized state, composite map of ATD-LBD-TMD
Method: single particle / : Yen LY, Newton TP, Gangwar SP, Sobolevsky AI

EMDB-75112: 
SK3D-Matured in complex with GluN1-GluN2B, full refinement
Method: single particle / : Kleeman SO, Furukawa HF

EMDB-75120: 
OX1-Matured in complex with GluN1-GluN2B, full refinement
Method: single particle / : Kleeman SO, Furukawa HF

EMDB-75121: 
SK5A-Matured apo state in complex with GluN1-GluN2B, full refinement
Method: single particle / : Kleeman SO, Furukawa HF

EMDB-75122: 
SK5B-Matured in complex with GluN1-GluN2B, full refinement
Method: single particle / : Kleeman SO, Furukawa HF

EMDB-75123: 
SK3D-Germline in complex with GluN1-GluN2B, full refinement
Method: single particle / : Kleeman SO, Furukawa HF

EMDB-75127: 
SK5G-Matured in complex with GluN1-GluN2B, full refinement
Method: single particle / : Kleeman SO, Furukawa HF

EMDB-75128: 
OX1-Germline in complex with GluN1-GluN2B, full refinement
Method: single particle / : Kleeman SO, Furukawa HF

EMDB-75129: 
SK5A-Matured glycine/glutamate in complex with GluN1-GluN2B, full refinement
Method: single particle / : Kleeman SO, Furukawa HF

EMDB-75134: 
SK5G-Germline
Method: single particle / : Kleeman SO, Furukawa HF
Pages:
Movie
Controller
Structure viewers
About EMN search



wwPDB to switch to version 3 of the EMDB data model
